Over the past 20 yr, increased attention has been directed toward evaluation of urinary enzymes as markers of nephrotoxicity in dogs because the technique is noninvasive and Considered to be more sensitive than the more commonly used conventional tests of renal function. Urinary enzymes also have the potential of determining the primary site of renal damage bccause different sections of the nephron have a characteristic complement of enzymes. In dogs, increases in brush border enzymes, including y-glutamyl transferase and alkaline phosphatase, have been associated with renal proximal tubular damage, while increases in N-acetyl-P-D-ghcosaminidase have been observed in the early stage of renal papillary necrosis. Urinary enzymes have been particularly uscful in detection of acute renal damage in dogs, specifically tubular damage; however, their corresponding value in providing information about chronic renal damage remains to be established. Although elevation of certain enzymes appears to be a relatively sensitive measure of nephrotoxicity in the dog, there is no current agreement regarding which enzyme assays are the most appropriate for routine use in safety assessment studies. In addition, elevation of a single enzyme is of limited diagnostic value in detection of renal damage because spurious increases in urinary enzymes sometimes occur in normal dogs. Therefore, if one wishes to conduct special assessment of nephrotoxicity in dogs, evaluation of several enzymes at multiple time points is needed to compensate for normal enzyme variation and to identify potential anatomic site selectivity of the toxin.
INTRODUCTION
In drug safety evaluation, highly sensitive tests for renal injury are needed because changes in renal function tests and serum biochemical assays for kidney damage do not occur until >75% of nephrons have become nonfunctional (4) . Over the past 20 yr, increased attention has been directed toward evaluation or urinary enzymes as diagnostic markers of nephrotoxicity. Reviews of the use of urinary enzymes have been published for humans and various laboratory animals (20) (21) (22) (23) 26 ) but attention has not been focused on the dog. The purpose of this review is to give some general information about urinary enzymes and their application to evaluation of nephrotoxicity in the dog.
To better understand the changes of urinary enzymes under pathologic conditions, it is useful to first describe the physiology of urinary enzyme excretion. Under normal conditions, enzymatic activities of urine may originate from serum (as glomerular filtrate), renal tubular cells, and the urogenital tract (epithelial cells, glandular secretions, and semen). The contribution of serum enzymes to urine is negligible for most urinary enzymes because they are relatively large (>80,000 ma) and unable to pass through the normal glomerulus; however, the serum may be a source for lower molecular weight enzymes, including lysozyme (muramidase). Epithelial cells of the urogenital tract are also poor sources of urinary enzymes because the enzyme content of these cells is low. However, glandular secretions, especially in male animals, can be major contributors of urinary enzymes (22) . In dogs, semen has been demonstrated to be an * Address correspondence to: Frances A. S . Clenio, 6 Swans\vood Lane. Old Lynie, Connecticut 06371. important source of N-acetyl-P-D-glucosaminidase (NAG) (14, 19) .
ASSAY OF URINARY ENZYhlES-PRACTICAL CONSIDERATIONS
Methods for measuring urinary enzymes are generally similar to those used for assaying comparable serum enzymes; however, certain limitations and cautions should be considered because several it2 vivo and in vitro factors can affect enzyme activity in urine (Table I) (20) . Close attention should be paid to the quality of urine because red blood cells, white blood cells, feces, and bacteria may increase or decrease the enzyme activity (20, 22) . The volume and time of urine collection must be carefully noted. The urinary enzyme concentration is generally expressed as the activity excreted per unit time, usually per hour. In the dog, urinary enzymes have also been expressed in relation to creatinine, which allows for the collection of short-timed or "spot" urine samples (9, 10, 27) . The sex of animal should also be noted because the amount of urinary NAG in male dogs is approximately twice that of females (14, 19) . Urine may also contain endogenous, low molecular weight enzyme inhibitors and activators so that preparation of urine by gel filtration or dialysis may be necessary prior to analysis (28); however, it has not been well established which enzyme assays require such preparation in the dog (9, 24) . Because the kidney is involved in excretion of drugs, it also may be necessary to consider any potential interference of enzyme activity by drugs. Certain in vitro factors, including handling, processing, and storage of urine in the laboratory, can also affect enzyme activity and lead to erroneous results. Therefore, in toxicity studies, the conditions for urine collection and enzyme measurement should be established to minimize the previously described itt vivo 29 0192-6233/98$3.00+$0.00
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TOXICOLOGIC PATHOLOGY and iit vitro factors that may affect enzyme activity in urine.
Many different urinary enzymes have been used to evaluate for nephrotoxicity in the dog (Table 11) . Currently, there is no consensus on which enzymes are the best to use, but 2 of the more commonly used enzymes include y-glutamyl transferase (GGT) and NAG. In the dog, GGT and NAG are good enzymes to measure because they are relatively stable at room temperature and 4OC and may be measured in urine supernatant without prior removal of enzyme inhibitors (9, 18, 24) . Other urinary enzymes, including alkaline phosphatase (ALP), leucine aminopeptidase (LAP), acid phosphatase (ACP), alanine aminopeptidase (AAP), lactate dehydrogenase (LDH), P-glucuronidase (P-GLU), P-galactosidase (P- GAL) , and lysozyme (muramidase), have also been evaluated in the dog.
USE OF URINARY ENZYhlES IN NEPHROTOXICITY
In dogs, urinary enzymes have primarily been used for evaluation of acute nephrotoxicity (Table 111) because they provide a sensitive noninvasive test for renal damage, which can be used within the confines 'of safety assessment studies. Elevation of certain urinary enzymes (GGT, NAG, P-GLU, and muramidase) have been shown to be superior to blood urea nitrogen (BUN), serum creatinine, creatinine clearance, urine protein excretion, and urine specific gravity in detection of gentamicin-induced, acute tubular necrosis (1, 2, 5, 11, 25) . Additionally, a study in which mercuric chloride was administered in gradually increasing doses to dogs demonstrated that increases in urinary enzymes (ALP and ACP) occurred well in advance of any detectable changes in renal function tests or renal histology (7) .
Because different sections of the nephron contain a characteristic complement of enzymes (Table 11) (12) , urinary enzymes can also be used to localize the site of renal damage. Those enzymes within the proximal tubule (GGT, ALP, and aminopeptidases) have been shown to be good markers of proximal tubular damage in the dog (1, 2, 5 , 7, 25) . A study where ethyleneimine was administered to dogs demonstrated that increases in NAG were associated with early papillary necrosis and that these increases in NAG preceded the excretion of other enzymes (ALP, ACP, P-GLU, and P-GAL), which were more indicative of secondary cortical tubular involvement (6) . The use of urinary enzymes to monitor glo- serum and reabsorbed in proximal tubule merular injury is of limited value because of the lack of specific glomerular markers and the problem of discriminating between increases in urinary enzyme that might originate from either abnormal concentration in blood or abnormal glomerular function. The determination of isoenzyme forms of such enzymes as LDH; ALP, and NAG may help determine the origin (blood vs renal) of urinary enzyme elevation. Besides the potential to localize damage within nephron, urinary enzymes can also be used as subcellular markers of renal damage because of their location within brush border, cytosol, lysosomes, and mitochondria (Table 11) . Urinary enzymes may also be used to assess the amount of renal damage because the degree of increase of enzymuria generally correlates with the severity of renal damage, a feature observed in a study where dogs received different doses of gentamicin (5) . However, the potential of urinary enzymes to detect minor degrees of renal damage may be limited by the clinically significant wide biological variation of enzyme activity that has been reported for some enzymes (GGT, NAG, and AAP) in 
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Ischemic damage to NAG, LDH, LAP. lysozyme 15-17 nephron healthy dogs (9, 11, 24) . Therefore, when trying to detect minor degrees of renal damage, it is important to limit the previously described in vivo and in vitro factors that may contribute to the biological variation of some urinary enzymes.
Urinary enzymes can also provide information about the progression and recovery of renal damage because enzymes vary with the activity of renal disease. In dogs treated with gentamicin for 10 days, the concentration of urinary GGT slowly increased as the renal damage progressed (25) . On the other hand, in a study where dogs were treated with a single dose of maleic acid, a decline in urinary enzyme activity was considered a measure of the rate of recovery from renal injury (Clemo et al, personal communication). In this study, increases in several urinary enzymes (GGT, NAG, ALP, and LDH) were associated with acute proximal tubular necrosis, while return of these urinary enzyme levels to pretreatment levels was associated with repair of renal damage, supported by microscopic finding of proximal tubular regeneration (Clemo et al, personal communication).
While urinary enzymes have been shown to be of value in detection of acute tubular damage in the dog, their corresponding value in the diagnosis of chronic renal damage remains to be established. In evaluation of urinary enzymes in dogs with spontaneous renal disease, no increases in GGT or ALP were associated with chronic renal disease, but an increase in ALP was associated with acute renal disease (13) . To further evaluate the value of urinary enzymes in the diagnosis of chronic renal damage in the dog, additional experimental models of chronic nephrotoxicity are needed.
One problem with using urinary enzymes to assess renal damage is that they are sometimes too sensitive; elevations may be present in the absence of any other measurable renal abnormalities. This finding may reflect the ability of the kidney to recover rapidly from damage; however, it often relates to situations where only sporadic enzyme assays have been carried out, and sequential daily assays often overcome this problem. Another problem with the use of urinary enzyme measurements is that increases in enzymes will sometimes only be seen during short periods after renal damage because the rate of excretion of enzymes varies, depending on the type and severity of renal damage. Therefore, evaluation of more than 1 enzyme at multiple time points is needed to properly evaluate for nephrotoxicity in the dog.
CONCLUSION
Urinary enzymes appear to be relatively sensitive, reliable markers of renal damage in the dog. Urinary enzymes have great potential in safety assessment studies because they are easier to measure than are most renal function tests. However, the validity of some enzyme assays is dill unproven; therefore, the results should be interpreted with caution when attempting to diagnose and localize the presence of renal damage. Furthermore, the elevation of a single enzyme at a single time point is of limited diagnostic value; rather, the evaluation of several urinary enzymes at different time points, along with other renal parameters (serum BUN and creatinine, quantitative urine protein, glucose and electrolytes, and urinalysis), should be correlated when assessing for nephrotoxicity in the dog. If urinary enzymes are to be used as clinical diagnostic markers of nephrotoxicity in safety assessment studies, a pilot study should be conducted to establish an "in-house" protocol for the collection and processing of urinary samples and baseline data for the urinary enzymes of interest in healthy dogs.
